Global burden of liver disease: 2023 update
Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …
Advancing the global public health agenda for NAFLD: a consensus statement
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …
approximately one-quarter of the global adult population, causing a substantial burden of ill …
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
The term non-alcoholic fatty liver disease (NAFLD), and its definition, have limitations for
both adults and children. The definition is most problematic for children, for whom alcohol …
both adults and children. The definition is most problematic for children, for whom alcohol …
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
T Kawaguchi, T Tsutsumi, D Nakano… - Clinical and …, 2021 - pmc.ncbi.nlm.nih.gov
Fatty liver is now a major cause of liver disease in the Asia-Pacific region. Liver diseases in
this region have distinctive characteristics. First, fatty liver is frequently observed in …
this region have distinctive characteristics. First, fatty liver is frequently observed in …
Metabolic dysfunction-associated fatty liver disease: a year in review
The transformation in name and definition from NAFLD to MAFLD represents an important
milestone, which indicates significant tangible progress towards a more inclusive, equitable …
milestone, which indicates significant tangible progress towards a more inclusive, equitable …
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases
With the global epidemics of obesity and associated conditions, including type 2 diabetes,
metabolic dysfunction-associated fatty liver disease, chronic kidney disease, hypertension …
metabolic dysfunction-associated fatty liver disease, chronic kidney disease, hypertension …
Metabolic dysfunction–associated fatty liver disease and the risk of 24 specific cancers
Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is a significant
health issue closely associated with multiple metabolic dysfunctions. The association …
health issue closely associated with multiple metabolic dysfunctions. The association …
Comparing the diagnostic criteria of MAFLD and NAFLD in the Chinese population: a population-based prospective cohort study
C Yu, M Wang, S Zheng, M **a, H Yang… - Journal of clinical …, 2021 - pmc.ncbi.nlm.nih.gov
Background and Aims Metabolic dysfunction-associated fatty liver disease (MAFLD) is a
new concept, proposed in 2020; however, its applicability in Asia populations has yet to be …
new concept, proposed in 2020; however, its applicability in Asia populations has yet to be …
NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways
Non-alcoholic fatty liver disease (NAFLD) is now the most common cause of chronic liver
disease, worldwide. The molecular pathogenesis of NAFLD is complex, involving numerous …
disease, worldwide. The molecular pathogenesis of NAFLD is complex, involving numerous …
The NAFLD‐MAFLD debate: Is there a Consensus‐on‐Consensus methodology?
Polarizing opinions have recently arisen in hepatology on the name and redefinition of fatty
liver disease associated with metabolic dysfunction. In spite of growing and robust evidence …
liver disease associated with metabolic dysfunction. In spite of growing and robust evidence …